Dr James A. Bristol

Dr Bristol’s career in drug discovery research and development spans over 32 years and includes senior positions at Schering-Plough, Parke-Davis, and Pfizer. Most recently, he held the position of Senior Vice President, Worldwide Drug Discov…

Read more

Professor Chris Reilly

Professor Reilly has extensive experience guiding life science projects, portfolios and investment decisions. He advises biotechs, VCs, medical charities, academics, and was on the 2014 REF committee. He is a Professor of Practice at KCL and a Boa…

Read more

Dr Phillip Hawkins

Dr Hawkins is Senior Group Leader at the Babraham Institute, Cambridge, UK. He received a BSc from the University of Bristol and a PhD from the University of Birmingham. After post-doctoral training at SK&F Research Ltd., he joined the MRC Cam…

Read more

Dr Len Stephens

Dr Stephens is Senior Group Leader at the Babraham Institute, Cambridge, UK. He received a BSc and a PhD from the University of Birmingham, and joined the Babraham Institute following post-doctoral training at SK&F Research Ltd. He is an elect…

Read more

Professor Bart Vanhaesebroeck

Professor Vanhaesebroeck is Professor of Cell Signalling at the UCL Cancer Institute in London. Following a PhD from Ghent University, Belgium, he carried out postdoctoral studies at the Ludwig Institute at University College London (UCL) where he…

Read more

Professor Patrick Matthias

Professor Matthias is a Senior Group Leader at the Friedrich Miescher Institute for Biomedical Research in Basel. He studies the biology of Histone Deacetylases, and his laboratory has made major contributions to understanding the function of seve…

Read more

Dr Paul Rennert

Paul is President & CSO of Aleta Biotherapeutics and Founder & Principal of Sugarcone Biotech LLC. Paul's industry expertise covers bench to clinical trial development of diverse therapeutics for oncology, autoimmunity, inflammation an…

Read more

Professor Klaus Okkenhaug

Klaus Okkenhaug obtained his BSc from the University of Victoria, British Columbia, Canada, and a PhD in Immunology from the University of Toronto. In 1999, he joined Bart Vanhaesebroeck's group at the Ludwig Institute for Cancer Research as a…

Read more

Professor Jonathan Backer

Professor Backer is the Williams S. Lasdon Professor and Chairman of the Department of Molecular Pharmacology at the Albert Einstein College of Medicine in New York. His research is focused on the biology of the PI3K enzyme family, including of pa…

Read more

Professor Jeff Evans

Professor Evans is Professor of Translational Cancer Research and Director of the Institute of Cancer Sciences, University of Glasgow. He is also Honorary Consultant in Medical Oncology at the Beatson West of Scotland Cancer Centre, Glasgow, Group…

Read more

Dr Richard Groves

Dr Groves is a Consultant Dermatologist with a particular interest in complex medical dermatology. He runs a tertiary clinical and diagnostic service for patients with immunologically mediated skin diseases based at the St. John's Institute of D…

Read more